These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28865249)

  • 1. Effects of ultra-low-dose versus standard hormone therapy on fibrinolysis and thrombin generation in postmenopausal women.
    Piróg M; Jach R; Undas A
    Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():77-82. PubMed ID: 28865249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of the ultra-low dose and standard estrogen plus dydrogesterone therapy on thrombin generation and fibrinolysis in postmenopausal women.
    Piróg M; Jach R; Kacalska-Janssen O
    Acta Obstet Gynecol Scand; 2017 Dec; 96(12):1438-1445. PubMed ID: 28981954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration.
    Połać I; Borowiecka M; Wilamowska A; Nowak P
    Gynecol Endocrinol; 2013 Feb; 29(2):165-8. PubMed ID: 23116237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in hemostatic parameters after oral hormone therapy in postmenopausal women.
    Borowiecka M; Polac I; Nowak P; Radwan P; Ponczek MB; Wachowicz B
    J Womens Health (Larchmt); 2010 Dec; 19(12):2267-70. PubMed ID: 21054215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of two oral doses of 17beta-estradiol associated with dydrogesterone on thrombin generation in healthy menopausal women: a randomized double-blind placebo-controlled study.
    Rousseau A; Robert A; Gerotziafas G; Torchin D; Zannad F; Lacut K; Libersa C; Dasque E; Démolis JL; Elalamy I; Simon T
    Fundam Clin Pharmacol; 2010 Apr; 24(2):239-45. PubMed ID: 19719551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced protein carbonylation on hormone therapy is associated with improved fibrinolysis in postmenopausal women: the impact of PAI-1 and TAFI activity.
    Piróg M; Ząbczyk M; Natorska J; Jach R; Undas A
    J Thromb Thrombolysis; 2024 Jul; ():. PubMed ID: 38981979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis.
    Eilertsen AL; Sandvik L; Mowinckel MC; Andersen TO; Qvigstad E; Sandset PM
    Thromb Res; 2007; 120(3):371-9. PubMed ID: 17156824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?
    Brosnan JF; Sheppard BL; Norris LA
    Thromb Haemost; 2007 Apr; 97(4):558-65. PubMed ID: 17393018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ultra-low-dose estradiol and dydrogesterone on arterial stiffness in postmenopausal women.
    Matsui S; Yasui T; Tani A; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Arisawa K; Irahara M
    Climacteric; 2014 Apr; 17(2):191-6. PubMed ID: 24164272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone.
    Norris LA; Brosnan J; Bonnar J; Conard J; Kluft C; Hellgren M
    Thromb Haemost; 2008 Aug; 100(2):253-60. PubMed ID: 18690345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study.
    Post MS; van der Mooren MJ; van Baal WM; Blankenstein MA; Merkus HM; Kroeks MV; Franke HR; Kenemans P; Stehouwer CD
    Am J Obstet Gynecol; 2003 Nov; 189(5):1221-7. PubMed ID: 14634544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in hemostatic parameters after oral and transdermal hormone therapy in postmenopausal women.
    Polac I; Borowiecka M; Wilamowska A; Bijak M; Ponczek MB; Nowak P
    Gynecol Endocrinol; 2011 Sep; 27(9):692-5. PubMed ID: 20979540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature.
    Douketis JD; Gordon M; Johnston M; Julian JA; Adachi JR; Ginsberg JS
    Thromb Res; 2000 Jul; 99(1):25-34. PubMed ID: 11012376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH Antagonist Protocol Enhances Coagulation During Controlled Ovarian Stimulation for IVF.
    Piróg M; Kacalska-Janssen O; Jach R; Wyroba J; Chrostowski B; Ząbczyk M; Natorska J
    Reprod Sci; 2022 Dec; 29(12):3521-3531. PubMed ID: 35821349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma is associated with enhanced thrombin formation and impaired fibrinolysis.
    Bazan-Socha S; Mastalerz L; Cybulska A; Zareba L; Kremers R; Zabczyk M; Pulka G; Iwaniec T; Hemker C; Undas A
    Clin Exp Allergy; 2016 Jul; 46(7):932-44. PubMed ID: 27019085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hormone therapy on the enteroinsular axis.
    Sztefko K; Rogatko I; Milewicz T; Józef K; Tomasik PJ; Szafran Z
    Menopause; 2005; 12(5):630-638. PubMed ID: 16145319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hormone replacement therapy on coagulation and fibrinolysis in postmenopausal women.
    Koh KK
    Int J Hematol; 2002 Aug; 76 Suppl 2():44-6. PubMed ID: 12430899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.